Thrivent Financial for Lutherans grew its stake in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 206.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 35,223 shares of the company’s stock after purchasing an additional 23,731 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.08% of Azenta worth $1,761,000 as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of AZTA. Picton Mahoney Asset Management raised its stake in Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company’s stock valued at $35,000 after buying an additional 532 shares in the last quarter. KBC Group NV increased its holdings in shares of Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after acquiring an additional 698 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Azenta during the 4th quarter valued at approximately $200,000. Catalyst Funds Management Pty Ltd lifted its stake in Azenta by 123.0% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 4,684 shares of the company’s stock worth $234,000 after purchasing an additional 2,584 shares during the last quarter. Finally, Empowered Funds LLC acquired a new position in Azenta in the fourth quarter worth $293,000. Institutional investors own 99.08% of the company’s stock.
Analysts Set New Price Targets
AZTA has been the topic of a number of research reports. Needham & Company LLC increased their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday, February 6th. Stephens reiterated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a research note on Thursday, January 2nd. TD Cowen upgraded Azenta to a “hold” rating in a research note on Thursday, February 27th. Finally, Evercore ISI increased their price target on Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a research report on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $58.75.
Azenta Stock Down 2.6 %
Shares of NASDAQ:AZTA opened at $34.61 on Friday. Azenta, Inc. has a fifty-two week low of $33.37 and a fifty-two week high of $63.58. The company has a market cap of $1.58 billion, a PE ratio of -11.61 and a beta of 1.52. The company’s 50-day moving average price is $45.11 and its 200 day moving average price is $46.27.
Azenta (NASDAQ:AZTA – Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, equities analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current year.
Azenta Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Stories
- Five stocks we like better than Azenta
- What is a Special Dividend?
- MarketBeat Week in Review – 03/24 – 03/28
- How to Short a Stock in 5 Easy Steps
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- When to Sell a Stock for Profit or Loss
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.